LIVE SESSION BRIEF Medical Devices $25.91B Cap Quant: HOLD

DexCom, Inc. (DXCM) — Live Session & Technical Brief

Updated Nov 21, 2026 5:51 PM ET · Prev Close $80.19

Pro Workspace
Last Session Price
$79.32 -1.08%
-$0.87 vs $80.19 prior close
Intraday Range
$78.75 – $81.58
Open $80.48
Relative Volume
0.92x Avg
4,418,716 sh
52-Week Range
$56.72 – $92.59
Benchmark Alpha
+2.56% vs SPY
+4.59% vs QQQ
20-Session Trend +1.0%
Sector Domino Phase 1: Healthy Score 37/100 · Healthcare, MedTech & Managed Care (XLV)
View Full Sector Domino & 3-Stack Radar →

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.08%) in Medical Devices

DexCom, Inc. (DXCM) is trading within a tight intraday band at $79.32 (-1.08%, 0.92x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, DXCM is outperforming the S&P 500 by +2.56%. 14-day RSI stands at 43.0, keeping momentum in a bearish regime.

NEWS 70% Weight
Global Clinical-Grade Wearables for Pharma and Biotech Market Report 2026 Capitalize on 21.5 CAGR to 7.48B by 2030 as Abbott, Medtronic, DexCom and Philips Scale AI-Driven RPM

Boost ROI with AI analytics, remote monitoring, cloud-based real-world evidence, precision biomarker tracking and wearable injectors that enable at-home biologic delivery.Dublin, Nov. 19, 2026 Globe Newswire -- Clinical-

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($79.32) trades relative to 20-day SMA ($81.49) and 50-day SMA ($83.94).

Volume Confirmation
MODERATE VOLUME (0.92x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

DXCM outperforming the S&P 500 by +2.56%
DXCM Session
-1.08%
$79.32
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +2.56% Alpha vs QQQ: +4.59% Alpha vs XLV: -0.96%
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $81.61 · IV 39.6%

DXCM Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($8,161)

Compare $8,161 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 39.6% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $80 / $90 Bull Call Spread

Buy 1x $80C · Sell 1x $90C · 31d

Net Entry $482 Debit
T+5d @ +5% Move +$136 (+28%)
Max Risk / Buffer $482 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $75 / $70 Bull Put Spread

Sell 1x $75P · Buy 1x $70P · 31d

Net Entry $86 Credit
Max Credit / Yield +$86 (+20.8% RoM)
Max Risk / Buffer -9.2% Cushion ($414 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $85 / $75 Bear Put Spread

Buy 1x $85P · Sell 1x $75P · 31d

Net Entry $380 Debit
T+5d @ -5% Drop +$186 (+49%)
Max Risk / Buffer $380 Capped
5d Edge & Liquidity 1.0x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Recent DXCM Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$76.74
Short-term support band
Upper Bound
$81.90
Short-term resistance band
Key Inflection Level
$81.49 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $81.49 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (DXCM)

BEARISH MA TREND
RSI (14)
43.0
Bearish
20-Day SMA
$81.49
Below 20d
50-Day SMA
$83.94
Below 50d
MACD Signal
Bearish
MACD -0.82
ADX (14)
12.4
Weak trend
10d Momentum
-0.09
Soft 10-day momentum

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 1.1
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

DexCom expects a record number of new patients in 2026 due to potential Medicare coverage expansion for continuous glucose monitoring, with the decision from the Centers for Medicare and Medicaid Services (CMS) anticipated before year-end.

Reddit communities: 1 comment (Bullish)

About DexCom, Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Sector
Healthcare
Market Cap
$25.91B
Forward P/E
24.0x
Employees
10,300

Get Instant DXCM Catalyst Alerts

Receive an email alert when DXCM triggers an unusual volume breakout, options sweep, or rating shift.

DXCM Session & Catalyst FAQ

Why is DXCM stock trading near flat today?

DexCom, Inc. (DXCM) is trading within a tight intraday band at $79.32 (-1.08%, 0.92x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, DXCM is outperforming the S&P 500 by +2.56%. 14-day RSI stands at 43.0, keeping momentum in a bearish regime.

Is DXCM stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.92x relative volume (moderate participation). Our multi-factor model currently rates DXCM as HOLD. Review full valuation, quality, and timing signals on the DXCM Buy or Sell Decision Brief →

What is DXCM's intrinsic value and expected trading range?

At $79.32, DXCM's modeled 1-to-3 session range is $76.74 – $81.90, with a key inflection level at $81.49 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the DXCM Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for DXCM?

RSI at 43.0 reflects soft below-midline momentum. DXCM trades at $79.32 relative to its 20-day SMA ($81.49) and 50-day SMA ($83.94), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs